Source: Katie Thomas, NY TIMES, 11/1/19

President Trump said Friday that he intended to nominate Dr. Stephen M. Hahn, a top executive at The University of Texas M.D. Anderson Cancer Center, to be the next commissioner of the Food and Drug Administration. If he is confirmed by the Senate, Dr. Hahn would fill the vacancy left by Dr. Scott Gottlieb, who stepped down as commissioner in April. In doing so, he passed over the acting commissioner, Dr. Norman E. Sharpless, who had the support of previous commissioners and an array of patient groups.

For more of this story, click here.